Analysis of histamine and sisomicin in gentamicin: Search for the causative agents of adverse effects. Issue 12 (24th August 2021)
- Record Type:
- Journal Article
- Title:
- Analysis of histamine and sisomicin in gentamicin: Search for the causative agents of adverse effects. Issue 12 (24th August 2021)
- Main Title:
- Analysis of histamine and sisomicin in gentamicin: Search for the causative agents of adverse effects
- Authors:
- Wohlfart, Jonas
Holzgrabe, Ulrike - Abstract:
- Abstract: In 1998, the aminoglycoside antibiotic gentamicin sulfate caused several cases of deaths in the United States, after the switch from twice‐ to once‐daily application. Endotoxins were discussed as the cause for the adverse effects and sisomicin was identified as the lead impurity; batches containing sisomicin were contaminated with more impurities and were responsible for the fatalities. In 2016, anaphylactic reactions in horses, and later in humans with one fatality, were observed after application of gentamicin sulfate contaminated with histamine. To determine whether histamine was responsible for the 1990s death cases as well, histamine was quantified by means of liquid chromatography–tandem mass spectrometry (LC‐MS/MS) in 30 samples of gentamicin sulfate analyzed in previous studies. Furthermore, a relative quantification of sisomicin was performed to check for a correlation between histamine and the lead impurity. A maximum amount of 11.52 ppm histamine was detected, which is below the limit for anaphylactic reactions of 16 ppm, and no correlation of the two impurities was observed. However, the European Medicines Agency recommends a stricter limit with regard to the maximum single dose of gentamicin sulfate to reach a greater gap between the maximum histamine exposition of 4.3 µg and the quantity known to cause hypotension of 7 µg. The low amounts of histamine and the fact that there is no connection with the contamination with sisomicin showed that histamineAbstract: In 1998, the aminoglycoside antibiotic gentamicin sulfate caused several cases of deaths in the United States, after the switch from twice‐ to once‐daily application. Endotoxins were discussed as the cause for the adverse effects and sisomicin was identified as the lead impurity; batches containing sisomicin were contaminated with more impurities and were responsible for the fatalities. In 2016, anaphylactic reactions in horses, and later in humans with one fatality, were observed after application of gentamicin sulfate contaminated with histamine. To determine whether histamine was responsible for the 1990s death cases as well, histamine was quantified by means of liquid chromatography–tandem mass spectrometry (LC‐MS/MS) in 30 samples of gentamicin sulfate analyzed in previous studies. Furthermore, a relative quantification of sisomicin was performed to check for a correlation between histamine and the lead impurity. A maximum amount of 11.52 ppm histamine was detected, which is below the limit for anaphylactic reactions of 16 ppm, and no correlation of the two impurities was observed. However, the European Medicines Agency recommends a stricter limit with regard to the maximum single dose of gentamicin sulfate to reach a greater gap between the maximum histamine exposition of 4.3 µg and the quantity known to cause hypotension of 7 µg. The low amounts of histamine and the fact that there is no connection with the contamination with sisomicin showed that histamine was not the cause for the death cases in the United States in 1998, and endotoxins remain the most probable explanation. Abstract : To determine whether histamine was responsible for several death cases reported in the 1990s in the United States, histamine was quantified by means of liquid chromatography–tandem mass spectrometry (LC‐MS/MS) in 30 samples of gentamicin sulfate analyzed in previous studies, and a relative quantification of sisomicin was also performed. The proven lack of connection with the contamination with sisomicin shows that histamine was not the cause for those death cases, while endotoxins remain the most probable explanation. … (more)
- Is Part Of:
- Archiv der Pharmazie. Volume 354:Issue 12(2021)
- Journal:
- Archiv der Pharmazie
- Issue:
- Volume 354:Issue 12(2021)
- Issue Display:
- Volume 354, Issue 12 (2021)
- Year:
- 2021
- Volume:
- 354
- Issue:
- 12
- Issue Sort Value:
- 2021-0354-0012-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-08-24
- Subjects:
- drug impurities -- gentamicin sulfate -- histamine -- LC‐MS/MS -- sisomicin
Pharmaceutical chemistry -- Periodicals
Pharmacology -- Periodicals
615.19 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-4184 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ardp.202100260 ↗
- Languages:
- English
- ISSNs:
- 0365-6233
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1622.800000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19971.xml